90.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NUVL Giù?
Forum
Previsione
Nuvalent Inc Borsa (NUVL) Ultime notizie
Custom strategy builders for tracking Nuvalent Inc.Portfolio Value Report & Risk Controlled Daily Trade Plans - newser.com
Regression analysis insights on Nuvalent Inc. performanceWeekly Loss Report & Risk Managed Investment Strategies - newser.com
Intraday pattern recognizer results for Nuvalent Inc.Earnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Stifel initiates coverage on Nuvalent stock with Buy rating By Investing.com - Investing.com South Africa
Stifel initiates coverage on Nuvalent stock with Buy rating - Investing.com
Cantor Fitzgerald initiates Nuvalent stock with Overweight rating By Investing.com - Investing.com Australia
Can trapped investors hope for a rebound in Nuvalent Inc.Portfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Forecasting Nuvalent Inc. price range with options dataWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Will Nuvalent Inc. stock rally after Fed decisionsJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Cantor Fitzgerald initiates Nuvalent stock with Overweight rating - Investing.com India
Multi asset correlation models including Nuvalent Inc.Market Performance Report & Expert Approved Momentum Trade Ideas - newser.com
Statistical indicators supporting Nuvalent Inc.’s strengthJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
Nuvalent to present new data on HER2 inhibitor at cancer conference - Investing.com Nigeria
Nuvalent to present new data on HER2 inhibitor at cancer conference By Investing.com - Investing.com South Africa
Preclinical intracranial activity: Nuvalent’s NVL-330 to be presented at AACR‑NCI‑EORTC Oct 24 - Stock Titan
How Nuvalent Inc. stock reacts to oil pricesBond Market & Entry Point Confirmation Signals - newser.com
What moving averages say about Nuvalent Inc.Trade Exit Summary & Weekly High Potential Stock Alerts - newser.com
Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 32% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Nuvalent To Participate In The UBS 2025 Virtual Oncology Day - Barchart.com
Is Nuvalent Inc. stock bottoming outVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com
Nuvalent (NASDAQ:NUVL) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Nuvalent Inc. stock trendline breakdown2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Is Nuvalent Inc. showing signs of accumulationJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
What MACD signals say about Nuvalent Inc.Trade Entry Report & Risk Managed Investment Strategies - newser.com
Is Nuvalent Inc. stock a buy before product launchesMarket Trend Review & Precise Buy Zone Tips - newser.com
The Escalator: Eli Lilly, Nuvalent, Lumen Bioscience and more - Medical Marketing and Media
Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year By Investing.com - Investing.com South Africa
Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year - Investing.com
J.P. Morgan Maintains Nuvalent(NUVL.US) With Buy Rating - 富途牛牛
Nuvalent, Inc. (NUVL) Stock Analysis: Promising Biotech With 38% Upside Potential - DirectorsTalk Interviews
What to expect from Nuvalent Inc. in the next 30 daysJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com
Will Nuvalent Inc. stock outperform Dow Jones index2025 Key Lessons & AI Driven Price Predictions - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):